Eiger Biopharmaceuticals Price on March 5, 2024
EIGRDelisted Stock | USD 0.74 0.03 3.90% |
If you're considering investing in Eiger Stock, it is important to understand the factors that can impact its price. As of today, the current price of Eiger Biopharmaceutica stands at 0.74, as last reported on the 13th of December 2024, with the highest price reaching 0.78 and the lowest price hitting 0.72 during the day. We have found twenty-three technical indicators for Eiger Biopharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Eiger Biopharmaceutica's Standard Deviation of 6.44, variance of 41.42, and Mean Deviation of 4.39 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
Eiger Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Eiger |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
EIGR |
Based on monthly moving average Eiger Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eiger Biopharmaceutica by adding Eiger Biopharmaceutica to a well-diversified portfolio.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Eiger Biopharmaceutica Stock history
Eiger Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eiger is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eiger Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eiger Biopharmaceutica stock prices may prove useful in developing a viable investing in Eiger Biopharmaceutica
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California. Eiger Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.
Eiger Biopharmaceutica Stock Technical Analysis
Eiger Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Eiger Biopharmaceutica Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Eiger Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eiger Biopharmaceutica December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Eiger Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eiger Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Eiger Biopharmaceutica stock market strength indicators, traders can identify Eiger Biopharmaceuticals entry and exit signals to maximize returns
Eiger Biopharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eiger Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Eiger Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eiger to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (1.33) | |||
Treynor Ratio | 0.6025 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Eiger Stock
If you are still planning to invest in Eiger Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eiger Biopharmaceutica's history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |